The Latest Breaking News from VillageMD

Walgreens (WBA) is attempting to turn around its struggling business with a new strategic vision and leadership, offering an enticing 10.7% dividend yield

With Walgreens Boots Alliance expected to release its Q4 earnings in October, analysts project a double-digit profit dip.

CHICAGO — CVS Health plans to buy Chicago-based Oak Street Health in a $10.6 billion deal that aims to expand CVS’s reach into primary care.

Oak Street Health runs primary care centers mostly for lower-to-middle income people with Medicare Advantage plans.

Walgreens and rival CVS have evolved in recent years far beyond their historic focus on store sales and filling prescriptions.

Chicago-based VillageMD, which has primary care clinics in Walgreens stores across the country, will pay $8.9 billion to acquire a company that will help it to branch into specialty and urgent care and grow its footprint dramatically.

Washington Post

RBC Capital Markets lowered the price target on Walgreens Boots Alliance Inc (NASDAQ:WBA) to $42 (10% upside) from $46 and maintained the Sector Perform rating. The analysts say that WBA posted solid fiscal 3Q22 results slightly ahead of their estimates and consensus on steady execution in the U.S. against a difficult comp and continued…

Walgreens Boots Alliance Inc (NASDAQ:WBA) has launched its clinical trial business to redefine the patient experience and increase access and retention in sponsor-led drug development research.  Walgreens will combine the flexible clinical trial model with its vast data on patient insights, partner-enabled health and technology capabilities, and in-person and virtual care options. The…